Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
PHAS holding history
PhaseBio Pharmaceuticals Inc in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PHAS overviewAll 13F holders of PHASFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −1,607,044−100.0% | Sold out | Holders |
| Q3 2022 | 1,607,044 | $283.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,607,044 | $964.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,607,044 | $2.12M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,607,044 | $4.19M | 0.5% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,607,044 | $5.00M | 0.4% | – | No prior filing | Holders |